Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve Unaudited Financial Results (Standalone & Consolidated) along with Limited Review Report for the first quarter ended on June 30, 2025 and to transact other businesses.